The CDP-ethanolamine pathway regulates skeletal muscle diacylglycerol content and mitochondrial biogenesis without altering insulin sensitivity

Genders, AJ; Jackowski, S; Febbraio, MA; Lee-Young, RS; Lamon, S; Risis, S; Meikle, PJ; McGee, SL; Selathurai, A; Sepulveda, P; Frank, M; Kowalski, GM; Bruce, CR; Watt, MJ; Burch, ML; Russell, AP
Abstract
Accumulation of diacylglycerol (DG) in muscle is thought to cause insulin resistance. DG is a precursor for phospholipids, thus phospholipid synthesis could be involved in regulating muscle DG. Little is known about the interaction between phospholipid and DG in muscle; therefore, we examined whether disrupting muscle phospholipid synthesis, specifically phosphatidylethanolamine (PtdEtn), would influence muscle DG content and insulin sensitivity. Muscle PtdEtn synthesis was disrupted by deleting CTP:phosphoethanolamine cytidylyltransferase (ECT), the rate-limiting enzyme in the CDP-ethanolamine pathway, a major route for PtdEtn production. While PtdEtn was reduced in muscle-specific ECT knockout mice, intramyocellular and membrane-associated DG was markedly increased. Importantly, however, this was not associated with insulin resistance. Unexpectedly, mitochondrial biogenesis and muscle oxidative capacity were increased in muscle-specific ECT knockout mice and were accompanied by enhanced exercise performance. These findings highlight the importance of the CDP-ethanolamine pathway in regulating muscle DG content and challenge the DG-induced insulin resistance hypothesis. Copyright © 2015 Elsevier Inc. All rights reserved.
Journal CELL METAB
ISSN 1550-4131
Published 05 May 2015
Volume 21
Issue 5
Pages 718-30
DOI 10.1016/j.cmet.2015.04.001
Type Journal Article
Sponsorship
NHMRC: 1004239, 1021168, 1042095, 586698, 1052573, 1042095, 1030474, 606460 NIH: GM0457370